Your browser doesn't support javascript.
loading
Eradication of persistent coxsackievirus B infection from a pancreatic cell line with clinically used antiviral drugs.
Honkimaa, Anni; Sioofy-Khojine, Amir-Babak; Oikarinen, Sami; Bertin, Antoine; Hober, Didier; Hyöty, Heikki.
Affiliation
  • Honkimaa A; Tampere University, Faculty of Medicine and Health Technology, Arvo Ylpönkatu 34, FIN-33520 Tampere, Finland. Electronic address: anni.honkimaa@tuni.fi.
  • Sioofy-Khojine AB; Tampere University, Faculty of Medicine and Health Technology, Arvo Ylpönkatu 34, FIN-33520 Tampere, Finland.
  • Oikarinen S; Tampere University, Faculty of Medicine and Health Technology, Arvo Ylpönkatu 34, FIN-33520 Tampere, Finland.
  • Bertin A; Université de Lille, CHU Lille Laboratoire de Virologie, EA3610, F-59000 Lille, France.
  • Hober D; Université de Lille, CHU Lille Laboratoire de Virologie, EA3610, F-59000 Lille, France.
  • Hyöty H; Tampere University, Faculty of Medicine and Health Technology, Arvo Ylpönkatu 34, FIN-33520 Tampere, Finland; Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland.
J Clin Virol ; 128: 104334, 2020 07.
Article in En | MEDLINE | ID: mdl-32450550
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Virus Replication / Enterovirus B, Human / Microbial Viability Limits: Humans Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2020 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Virus Replication / Enterovirus B, Human / Microbial Viability Limits: Humans Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2020 Document type: Article Country of publication: Netherlands